Clinical Trial Update: Oxidized Cellulose Hemostatic Agent in Thyroid Surgery: a Prospective Randomized Controlled Study [NA]

View source ↗

Summary

A prospective randomized controlled trial is evaluating the use of an oxidized cellulose hemostatic agent during thyroid surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Thyroid Diseases
• Thyroid Nodules

Drugs mentioned

• Oxidized cellulose hemostatic agent (oxidized regenerated cellulose)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Thyroid Nodule, Thyroid Diseases | NA | Status: UNKNOWN